These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24115766)

  • 21. Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRAS(G12D)-driven lung tumors.
    Guo JY; White E
    Autophagy; 2013 Oct; 9(10):1636-8. PubMed ID: 23959381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
    Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
    Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer metabolism in breadth and depth.
    Chun MG; Shaw RJ
    Nat Biotechnol; 2013 Jun; 31(6):505-7. PubMed ID: 23752435
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeting cellular adaptive responses to glutaminolysis perturbation for cancer therapy.
    Kim M; Hwang S; Jeong SM
    Mol Cells; 2024 Aug; 47(8):100096. PubMed ID: 39038517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating The Role Of Nitric Oxide Synthase In Oncogenic Ras-Driven Tumorigenesis.
    Counter C
    Redox Biol; 2015 Aug; 5():417. PubMed ID: 28162280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon source metabolism and its regulation in cancer cells.
    Yin C; Qie S; Sang N
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):17-35. PubMed ID: 22339657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic scavenging by cancer cells: when the going gets tough, the tough keep eating.
    Michalopoulou E; Bulusu V; Kamphorst JJ
    Br J Cancer; 2016 Sep; 115(6):635-40. PubMed ID: 27537393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer.
    Hutton JE; Wang X; Zimmerman LJ; Slebos RJ; Trenary IA; Young JD; Li M; Liebler DC
    Mol Cell Proteomics; 2016 Sep; 15(9):2924-38. PubMed ID: 27340238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the RAS-dependent chemoresistance: The Warburg connection.
    Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
    Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Approaches to RAS Mutation.
    Scott AJ; Lieu CH; Messersmith WA
    Cancer J; 2016; 22(3):165-74. PubMed ID: 27341593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers.
    Mattox TE; Chen X; Maxuitenko YY; Keeton AB; Piazza GA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of mitophagy in oncogenic K-Ras-induced transformation: overcoming a cellular energy deficit from glucose deficiency.
    Kim JH; Kim HY; Lee YK; Yoon YS; Xu WG; Yoon JK; Choi SE; Ko YG; Kim MJ; Lee SJ; Wang HJ; Yoon G
    Autophagy; 2011 Oct; 7(10):1187-98. PubMed ID: 21738012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation.
    Lock R; Roy S; Kenific CM; Su JS; Salas E; Ronen SM; Debnath J
    Mol Biol Cell; 2011 Jan; 22(2):165-78. PubMed ID: 21119005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hopefully devoted to Q: targeting glutamine addiction in cancer.
    Still ER; Yuneva MO
    Br J Cancer; 2017 May; 116(11):1375-1381. PubMed ID: 28441384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells.
    Yoo BH; Wu X; Li Y; Haniff M; Sasazuki T; Shirasawa S; Eskelinen EL; Rosen KV
    J Biol Chem; 2010 Feb; 285(8):5438-49. PubMed ID: 19778902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis.
    Issaq SH; Lim KH; Counter CM
    Mol Cancer Res; 2010 Feb; 8(2):223-31. PubMed ID: 20145037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy, Metabolism, and Cancer.
    White E; Mehnert JM; Chan CS
    Clin Cancer Res; 2015 Nov; 21(22):5037-46. PubMed ID: 26567363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras.
    Sung S; Choi J; Cheong H
    Oncotarget; 2015 Dec; 6(38):40405-17. PubMed ID: 26575954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation.
    Bettoun A; Joffre C; Zago G; Surdez D; Vallerand D; Gundogdu R; Sharif AA; Gomez M; Cascone I; Meunier B; White MA; Codogno P; Parrini MC; Camonis JH; Hergovich A
    Oncotarget; 2016 Jul; 7(28):44142-44160. PubMed ID: 27283898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ras proteins as therapeutic targets.
    Chakraborty A; Linnane E; Ross S
    Biochem Soc Trans; 2018 Oct; 46(5):1303-1311. PubMed ID: 30154091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.